91 related articles for article (PubMed ID: 30333217)
1. Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study.
Chen WC; Boursi B; Mamtani R; Yang YX
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):363-369. PubMed ID: 30333217
[TBL] [Abstract][Full Text] [Related]
2. Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.
Mamtani R; Lewis JD; Scott FI; Ahmad T; Goldberg DS; Datta J; Yang YX; Boursi B
PLoS Med; 2016 Apr; 13(4):e1002007. PubMed ID: 27116322
[TBL] [Abstract][Full Text] [Related]
3. Digoxin use is associated with pancreatic cancer risk but does not affect survival.
Boursi B; Huber JS; Haynes K; Mamtani R; Yang YX
Cancer Causes Control; 2021 Jan; 32(1):41-46. PubMed ID: 33064241
[TBL] [Abstract][Full Text] [Related]
4. The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom.
Carey FJ; Little MW; Pugh TF; Ndokera R; Ing H; Clark A; Dennison A; Metcalfe MS; Robinson RJ; Hart AR
Dig Dis Sci; 2013 Nov; 58(11):3308-12. PubMed ID: 23864194
[TBL] [Abstract][Full Text] [Related]
5. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
[TBL] [Abstract][Full Text] [Related]
6. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
Stolzenberg-Solomon RZ; Newton CC; Silverman DT; Pollak M; Nogueira LM; Weinstein SJ; Albanes D; Männistö S; Jacobs EJ
Am J Epidemiol; 2015 Aug; 182(3):187-97. PubMed ID: 26085045
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.
Bradley MC; Hughes CM; Cantwell MM; Napolitano G; Murray LJ
Br J Cancer; 2010 Apr; 102(9):1415-21. PubMed ID: 20372155
[TBL] [Abstract][Full Text] [Related]
8. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.
Khurana V; Sheth A; Caldito G; Barkin JS
Pancreas; 2007 Mar; 34(2):260-5. PubMed ID: 17312467
[TBL] [Abstract][Full Text] [Related]
9. Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study.
Saad A; Goldstein J; Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Mouallem M; Goldstein A; Giantonio B; Boursi B
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):599-604. PubMed ID: 32196836
[TBL] [Abstract][Full Text] [Related]
10. Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study.
Tascilar K; Dell'Aniello S; Hudson M; Suissa S
Arthritis Rheumatol; 2016 Nov; 68(11):2603-2611. PubMed ID: 27273914
[TBL] [Abstract][Full Text] [Related]
11. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan).
Lin Y; Kikuchi S; Tamakoshi A; Obata Y; Yagyu K; Inaba Y; Kurosawa M; Kawamura T; Motohashi Y; Ishibashi T;
Cancer Causes Control; 2006 Oct; 17(8):1077-82. PubMed ID: 16933058
[TBL] [Abstract][Full Text] [Related]
12. Statin use and the risk of pancreatic cancer: a population-based case-control study.
Chiu HF; Chang CC; Ho SC; Wu TN; Yang CY
Pancreas; 2011 Jul; 40(5):669-72. PubMed ID: 21654539
[TBL] [Abstract][Full Text] [Related]
13. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Juurlink DN; Targownik LE; Turin TC; Paterson JM; Ernst P;
BMJ; 2016 Feb; 352():i581. PubMed ID: 26888382
[TBL] [Abstract][Full Text] [Related]
14. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.
Walker EJ; Ko AH; Holly EA; Bracci PM
Cancer; 2015 Apr; 121(8):1287-94. PubMed ID: 25649483
[TBL] [Abstract][Full Text] [Related]
15. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
16. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
[TBL] [Abstract][Full Text] [Related]
17. Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.
McGlynn KA; Hagberg K; Chen J; Graubard BI; London WT; Jick S; Sahasrabuddhe VV
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25722350
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study.
Strasak AM; Pfeiffer RM; Brant LJ; Rapp K; Hilbe W; Oberaigner W; Lang S; Borena W; Concin H; Diem G; Ruttmann E; Glodny B; Pfeiffer KP; Ulmer H;
Ann Oncol; 2009 Jun; 20(6):1113-20. PubMed ID: 19164459
[TBL] [Abstract][Full Text] [Related]
19. Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence.
Keum N; Ha KH; Bao Y; Chung MJ; Kim HC; Giovannucci EL
Cancer Causes Control; 2018 Jan; 29(1):135-142. PubMed ID: 29197995
[TBL] [Abstract][Full Text] [Related]
20. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Olson SH; Hsu M; Wiemels JL; Bracci PM; Zhou M; Patoka J; Reisacher WR; Wang J; Kurtz RC; Silverman DT; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1414-20. PubMed ID: 24718282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
